AF
INBX

Allworth Financial’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Allworth Financial’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-88
Closed -$1.61K – 3700
2023
Q3 		$1.61K Hold
88
– – ﹤0.01% 2644
2023
Q2 		$2.29K Hold
88
– – ﹤0.01% 2427
2023
Q1 		$1.66K Buy
+88
New +$2.05K ﹤0.01% 2482

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Allworth Financial's INBX Position: Q4 2023 in Review

Allworth Financial sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2023, closing a stake of 88 shares — an estimated $1.61K sold.

Allworth Financial first reported a position in INBX in Q1 2023 and held it in 3 quarters. The position peaked at $2.29K in Q2 2023. 127 funds tracked by Wall St. Rank hold INBX as of Q4 2023.

  • Allworth Financial reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Allworth Financial sold 88 Inhibrx, Inc. Common Stock shares in Q4 2023, an estimated $1.61K.
  • Allworth Financial first reported a position in Inhibrx, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Allworth Financial's Inhibrx, Inc. Common Stock position peaked at $2.29K in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2023.

Based on Allworth Financial's 13F filing for Q4 2023, filed 24 Jan 2024.